Podcasts about dengue

Theo các chuyên gia, sốt xuất huyết Dengue đang diễn biến ngày càng khó lường. Chỉ trong 5 tháng đầu năm 2026, cả nước ghi nhận hơn 50.000 ca mắc, gấp 2,5 lần cùng kỳ năm trước, kéo theo số ca nặng phải nhập viện gia tăng.

A Secretaria de Saúde de Lauro Müller realiza nesta quarta-feira (10) uma ação de varredura e conscientização contra o mosquito Aedes aegypti, transmissor da dengue, zika e chikungunya. A mobilização acontece nas regiões do Centro, Sumaré e Bela Vista, com visitas domiciliares realizadas por agentes de endemias e agentes comunitários de saúde. Durante a ação, as equipes percorrem as residências para orientar os moradores, identificar possíveis criadouros do mosquito e distribuir materiais informativos sobre as medidas de prevenção. O objetivo é reforçar a participação da comunidade no combate à dengue, eliminando locais que possam acumular água. De acordo com o agente de endemias Edson Mazzucco, o município registra atualmente entre cinco e seis focos do mosquito, distribuídos em diferentes localidades, como os bairros Guatá, Barreiro e a região central. Em anos anteriores, também foram identificados focos no bairro Arizona, demonstrando que o problema não está concentrado em uma única área da cidade. Mazzucco destaca que o trabalho do poder público precisa ser acompanhado pelo compromisso da população. Segundo ele, cada morador deve manter seus terrenos e quintais limpos, evitando recipientes que possam acumular água e servir de ambiente para a reprodução do mosquito. O agente explicou ainda que, sempre que um foco é identificado, é realizada uma varredura em um raio aproximado de 300 metros. Após cerca de dois meses, uma nova vistoria é feita na mesma região para verificar se o problema foi eliminado ou se novas medidas precisam ser adotadas. Mesmo com a chegada do inverno, a orientação é para que os cuidados sejam mantidos. Conforme Mazzucco, o monitoramento realizado por meio de armadilhas permite acompanhar a presença do mosquito, mas o descarte inadequado de lixo e objetos que acumulam água pode favorecer o surgimento de novos focos, aumentando o risco de proliferação durante o verão. Edson Mazzucco participou de entrevista no jornalismo da Rádio Cruz de Malta, em conversa com o repórter Álvaro Souza, reforçando o apelo para que toda a população faça sua parte no combate à dengue e mantenha seus imóveis livres de possíveis criadouros do mosquito.

Hoje, ‘No Pé do Ouvido, com Yasmim Restum, você escuta essas e outras notícias: Dois óbitos e uma série de outras reações adversas estão sob investigação. Outros imunizantes contra dengue seguem sendo utilizados sem problemas pelo SUS. Ministro Nunes Marques, presidente do TSE, suspende pesquisa que apontou queda de Flávio Bolsonaro. Pressionados por Trump, Israel e Irã prometem interromper ataques. E documentário “Rua do Pescador, nº 6”, de Bárbara Paz, é premiado em festival de cinema na Itália.See omnystudio.com/listener for privacy information.

Dr. Esper Kallas - Diretor do Instituto Butantan - Dúvidas sobre a vacina da Dengue

Dr. Esper Kallas - Diretor do Instituto Butantan - Dúvidas sobre a vacina da Dengue

Dr. Esper Kallas - Diretor do Instituto Butantan - Dúvidas sobre a vacina da Dengue

O Ministério da Saúde suspendeu temporariamente a vacinação com o imunizante contra a dengue desenvolvido pelo Instituto Butantan.A decisão foi tomada após o registro de duas mortes sob investigação e 42 casos de reações severas possivelmente associadas à vacina.Mais de 500 mil doses já haviam sido aplicadas no país. Pessoas vacinadas nos últimos 21 dias foram orientadas a procurar acompanhamento médico para monitoramento de possíveis sintomas.O Butantan afirma que continuará colaborando com as autoridades sanitárias e destaca que a vacina apresentou eficácia de 79,6% contra a dengue e 89% contra casos graves em estudos clínicos.

Dr. Esper Kallas - Diretor do Instituto Butantan - Dúvidas sobre a vacina da Dengue

Dr. Esper Kallas - Diretor do Instituto Butantan - Dúvidas sobre a vacina da Dengue

Dr. Esper Kallas - Diretor do Instituto Butantan - Dúvidas sobre a vacina da Dengue

Confira nesta edição do JR 24 Horas: O Ministério da Saúde suspendeu a aplicação da vacina do Butantan contra a dengue em todo o país. A decisão ocorreu após duas mortes suspeitas e de uma terceira ocorrência considerada grave entre pessoas que receberam o imunizante. E ainda: Donald Trump exige que Israel e Irã interrompam ataques.

O Ministério da Saúde suspendeu temporariamente a vacinação contra a dengue com a vacina do Instituto Butantan após o registro de duas mortes suspeitas, que estão sendo investigadas. Foram notificadas 3.703 reações adversas, sendo 42 casos considerados graves. Todos os episódios estão sob investigação. O Giro de Notícias mantém você por dentro das principais informações do Brasil e do mundo. Confira mais atualizações na próxima edição.

O Aos Fatos desta segunda-feira (8) destaca a reação do governo federal à decisão da União Europeia de retirar o Brasil da lista de países autorizados a exportar produtos de origem animal para consumo humano.

CDMX otorga la declaración de Patrimonio Natural a dos ahuehuetes Los embajadores deben limitarse a la colaboración bilateral: Sheinbaum Israel realiza nuevos bombardeos contra Hezbolá #grc

Pledge here! Just a dollar a month can help keep us alive! https://www.patreon.com/user?u=2652072&ty=h&u=2652072 EXCLUSIVE replays of hour plus long live shows are available here at $5 a month or more! GET 10% OFF ON SHILAJIT FROM DR. KAUFMAN WHEN YOU USE CODE WAM10 HERE: https://medauthentica.com/discount/WAM10?redirect=/products/authentica-shilajit%3Fsca_ref=10867124.wrNV3jkYSaMg9 GET YOUR APRICOT SEEDS at the life-saving Richardson Nutritional Center HERE: https://rncstore.com/r?id=bg8qc1 Use code JOSH to save money! GET HEIRLOOM SEEDS & NON GMO SURVIVAL FOOD HERE: https://heavensharvest.com/wam USE Code WAM to save 25% plus free shipping! USE Code WAM50 for 50% off on select items like the #10 cans & MRE packs! Josh Sigurdson reports on the plan by Google to release millions of genetically modified mosquitoes into California as well as Florida in order to "stop mosquito-borne diseases which absolutely no one is buying. Google's decade old program called the "Debug Initiative" plans to release 32 million Culex mosquitoes into California, targeting West Nile, Dengue, Zika, Chikungunya, St. Louis Encephalitis and Yellow Fever. This is similar to past programs run via Bill Gates with what the government calls "flying syringes" meant to inject people with so-called "antidotes." In places like Africa where similar releases have been done, we've seen massive growths of dangerous illnesses. Absolutely no one trusts this initiative. The mosquitoes will be guided by AI and robotics. Yes, you read that right. Most people are missing that important point. This also seems to be happening at the same time as we see an explosion in Lone Star Ticks which cause people to have anaphylactic meat and dairy allergies which they call Alpha Gal Syndrome. In the 1960s, the US military interestingly weaponized Lone Star Ticks and dropped 270,000 of them into population centers. Since then, government whistleblowers have also come forward claiming they were paid to drop boxes of these ticks from helicopters into populated and wooded areas. With Martha's Vineyard alone seeing a 50% rate of Alpha Gal Syndrome, clearly this is a massive problem. Were these ticks engineered with neurotoxins? It also so happens that Bill Gates has been invested heavily in genetically modified ticks and the release of them under the guise of "stopping illnesses" while also funding the largest scale lab made meat initiatives which just happen to not negatively affect people with Alpha Gal Syndrome. So what's actually going on? From the mosquito release to Lyme Disease, from Lone Star Ticks to nanotech studied by Johns Hopkins, we delve into this extremely concerning issue which is hitting the United States and Canada hard right now. Stay tuned for more from WAM! BUY GOLD HERE: https://firstnationalbullion.com/schedule-consult/ Avoid CBDCs! HELP SUPPORT US AS WE DOCUMENT HISTORY HERE: https://gogetfunding.com/help-keep-wam-alive/# GET YOUR WAV WATCH HERE: https://buy.wavwatch.com/WAM Use Code WAM to save $100 and purchase amazing healing frequency technology! Get Your SUPER-SUPPLIMENTS HERE: https://vni.life/wam Use Code WAM15 & Save 15%! Life changing formulas you can't find anywhere else! Get local, healthy, pasture raised meat delivered to your door here: https://wildpastures.com/promos/save-20-for-life/bonus15?oid=6&affid=321 USE THE LINK & get 20% off for life and $15 off your first box! DITCH YOUR DOCTOR! https://www.livelongerformula.com/wam Get a natural health practitioner and work with Christian Yordanov! Mention WAM and get a FREE masterclass! You will ALSO get a FREE metabolic function assessment! PayPal: ancientwonderstelevision@gmail.com FIND OUR CoinTree page here: https://cointr.ee/joshsigurdson PURCHASE MERECHANDISE HERE: https://world-alternative-media.creator-spring.com/ JOIN US on SubscribeStar here: https://www.subscribestar.com/world-alternative-media For subscriber only content! BITCOIN ADDRESS: 18d1WEnYYhBRgZVbeyLr6UfiJhrQygcgNU World Alternative Media 2026

IMSS avanza en 19 obras hospitalariasLa Sonora Santanera llegará al Baile por la PazSismo de 6.1 sacude la costa de PerúMás información en nuestro Podcast#grc

Topic: Re-Emerging Infectious Diseases (Part 1): Hantavirus, Tick-Borne Diseases (STARI and Alpha-gal), Candida auris, Dengue, and MeaslesSpeakers:Renuga Vivekanandan, MD, Market VP CMO Physician Enterprise CHI Health Midwest, Professor, Creighton University School of MedicineChristopher Baliga, MD, NW Region Medical Director of Infection Prevention and Employee Health, SCrPT ID Co-Chair, CommonSpirit Health Infection Prevention Council, CommonSpirit Health

A preocupação com a dengue voltou a acender o alerta em Lauro Müller após o registro de novos focos do mosquito Aedes aegypti em comunidades do município. Nos últimos dias, a localidade de Barreiros passou a ser monitorada com maior atenção depois da confirmação do terceiro foco identificado em um curto período de tempo, situação que mobilizou equipes da Vigilância em Saúde e reforçou o alerta à população. De acordo com informações divulgadas pelo setor, agentes de combate às endemias e agentes comunitários de saúde intensificaram as vistorias nas áreas consideradas mais críticas, realizando visitas domiciliares, orientações aos moradores e ações de eliminação de possíveis criadouros do mosquito transmissor da dengue. Segundo o agente de combate a endemias de Lauro Müller, Edson Mazzucco, o município possui atualmente quatro focos confirmados do mosquito. Um deles foi identificado entre os bairros Centro e Sumaré, onde as revisões já foram realizadas e, até o momento, a situação está controlada. No entanto, a maior preocupação está concentrada na comunidade de Barreiros, onde três focos foram encontrados na mesma região. Conforme Mazzucco, o fato indica que os mosquitos estão circulando naquela área, elevando o risco de proliferação caso existam recipientes com água parada, lixo acumulado ou sucatas expostas. “O maior problema seria no Barreiros, porque estamos com três focos no mesmo local. Isso mostra que os mosquitos estão sobrevoando aquela área. Se acontecer de encontrarmos focos em lixo ou recipientes com água, aí a situação complica, porque podemos ter uma infestação”, alertou. O agente explicou ainda que os focos foram localizados em armadilhas instaladas estrategicamente para monitorar a presença do mosquito. As revisões continuam sendo realizadas de forma periódica, especialmente em áreas consideradas mais vulneráveis. A Vigilância em Saúde reforça que o apoio da comunidade é fundamental para impedir o avanço da dengue no município. “A população precisa ajudar. Somente os servidores não dão conta. Cada morador tem a responsabilidade de cuidar do seu terreno e eliminar qualquer recipiente que possa acumular água”, destacou Mazzucco. Paralelamente às ações em Barreiros, a Prefeitura de Lauro Müller também divulgou um cronograma de revisão dos focos de dengue no distrito de Guatá. As ações estão programadas para os dias 20 de maio, 24 de junho e 15 de julho, sempre às 8 horas da manhã, com acompanhamento dos agentes comunitários de saúde.

Edomex ofrecerá vacunas y esterilización gratuita Álvaro Obregón abrirá vacantes en su Feria del EmpleoPapa León XIV  llama a cuidar el planeta y construir la pazMás información en nuestro Podcast#grc

En Xochitepec, retiran 700 toneladas de cacharros  Este domingo en el Valle de México se pronostican lluvias fuertes  La OMS declara emergencia internacional por brote de ébola  Más información en nuestro podcast#grc

Podcast sobre la realidad actual del dengue en Risaralda, donde expertos en salud pública analizan su impacto epidemiológico, síntomas de alarma, estrategias de prevención y desafíos para el sistema de salud. Una conversación clara y cercana para entender cómo prevenir esta enfermedad y proteger a nuestras comunidades. 

Inicia jornada contra el Dengue y Chikungunya en el Edomex Posponen el Reciclatrón en la CDMX OMS confirma 11 casos de hantavirus de los Andes #grc

Organização Pan-Americana da Saúde afirma que supervisão de cada quintal conta; diretor Jarbas Barbosa defende reforço do setor com avanço tecnológico integral, unindo da saúde digital ao suporte em saúde mental.

Jornal da ONU, com Felipe de Carvalho:*Estatísticas Mundiais de Saúde têm avanços, mas mundo está longe das metas de 2030*Ataques com drones são principal causa de mortes na guerra no Sudão*Ciência e comunidade juntam-se na corrida contra a dengue nas Américas*Mundo não está preparado para eventual “Pandemia Digital”, alerta ONU

Con la Professoressa Eleonora Flacio, Ricercatrice senior e Responsabile Ecologia dei vettori presso l'Istituto di microbiologia della SUPSI, tratteremo dello Sviluppo di soluzioni innovative, sostenibili e scientificamente consolidate per il controllo della zanzara tigre, per ridurre il rischio sanitario e migliorare la qualità di vita della popolazione, sulla base di ricerche dell' istituto da lei diretto.

Con la Professoressa Eleonora Flacio, Ricercatrice senior e Responsabile Ecologia dei vettori presso l'Istituto di microbiologia della SUPSI, tratteremo dello Sviluppo di soluzioni innovative, sostenibili e scientificamente consolidate per il controllo della zanzara tigre, per ridurre il rischio sanitario e migliorare la qualità di vita della popolazione, sulla base di ricerche dell' istituto da lei diretto.

Nesta terça-feira, analisamos atualizações críticas na cardiologia e na saúde pública brasileira. Começamos pela aprovação da Anvisa de um novo medicamento para doenças cardiovasculares, ampliando as opções para perfis de risco específicos. Detalhamos a nova diretriz da American Society of Echocardiography sobre a mitigação de artefatos no ecocardiograma, essencial para evitar diagnósticos falsos de trombos e massas. Por fim, abordamos no Radar a ampliação da vacinação contra a dengue para pessoas de até 59 anos no Brasil, sinalizando uma mudança estratégica no enfrentamento da doença. Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/05-05-2026

Weingart, Christopher www.deutschlandfunk.de, Forschung aktuell

Send us Fan MailIt's a rare piece of good news. A single-dose dengue vaccine developed in Brazil as part of an international collaboration protected people against at least two strains of the virus for five years or longer, and did so safely. The vaccine was already being tested across Brazil and the findings helped boost confidence in its use. “This is a big deal,” says Dr. Andre Siqueira, Head of the Dengue Global Program at the Drugs for Neglected Diseases Initiative (DNDI).  Dr. Siqueira, who is also an Infectious Diseases Consultant at Brazil's Instituto Nacional de Infectologia Evandro Chagas, a hospital that is part of the Oswaldo Cruz Foundation (Fiocruz), helped develop the vaccine. He chatted with One World, One Health about the work in 2024. The new vaccine worked almost perfectly to keep people from being hospitalized with severe dengue symptoms, Dr. Siqueira and the team reported in Nature Medicine.  That's a big deal. Dengue can cause terrible symptoms, including severe abdominal pain, internal bleeding, severe muscle aches, and long term fatigue. From January 2025 to January 2026, dengue killed more than 4,000 people. The only other dengue vaccines currently available are a two-dose formula made by Japanese manufacturer Takeda and Sanofi's Dengvaxia, which the company is discontinuing because of a lack of demand. In this episode, Siqueira updates host Maggie Fox about the latest findings on the new vaccine's efficacy and its rollout in Brazil. 

Nesta edição, analisamos riscos neurológicos emergentes e os desafios éticos da informação digital, começando por um estudo da Fiocruz que alerta para o facto de a infecção por dengue poder aumentar em até 17 vezes o risco de desenvolver a Síndrome de Guillain-Barré. Investigamos como agências governamentais e farmacêuticas acabam por financiar indiretamente sites de desinformação médica através de publicidade programática. Por fim, abordamos no Radar um estudo transversal que avaliou 21 Modelos de Linguagem Grande (LLMs), revelando que, embora acertem diagnósticos finais, falham em mais de 80% das vezes na elaboração de diagnósticos diferenciais e na gestão de incertezas clínicas.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/17-04-2026

Em Cúpula Uma Só Saúde, na França, diretor da Organização Pan-Americana da Saúde lembra que em 2024, região teve mais de 13 milhões notificações da doença e 8,4 mil mortes.

Dr. Cordero-Baez, MD, Infectious Diseases Fellow at the Morsani USF College of Medicine, presents a lighthearted (and Bad Bunny-inspired) look at travel medicine recommendations for Puerto Rico, a popular travel destination (and his home country) in the Caribbean. Dr. Cordero starts by taking a close look at Dengue, for which cases experienced a surge on the island as recently as in 2024. He then discusses Zika virus, including the viruses epidemiology, transmission vectors, clinical manifestations, and complications. Chikungunya virus is also briefly discussed. He closes by discussing ciguatera poisoning and several other transmissible syndromes.

This is the first episode of the 'Quarterly catchup' series, in which CMI Communications editors discuss important and useful articles that have come out in the last 3 months to understand their results and potential clinical impact. In this inaugural episode of 'Quarterly catchup', Emily McDonald (Canada), Thomas Tängdén (Sweden) and Navaneeth Narayanan (USA) convene to discuss clinical microbiology and infectious diseases studies published in the first quarter of 2026 [1-6]. From Wolbachia-infected mosquitoes reducing dengue infection to exploration of antibiotic combination therapies against multidrug-resistant organisms, our hosts summarize six articles they found the most interesting, and discuss whether they can and should change clinical practice.   This episode was peer reviewed by Connor Prosty of McGill University, Montréal, Canada.  ReferencesLim JT, et al. Dengue suppression by Male Wolbachia-Infected mosquitoes. NEJM 2026. doi: https://doi.org/10.1056/NEJMoa2503304 Escrihuela-Vida F, et al. Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trial. Clin Infect Dis 2026. doi: https://doi.org/10.1093/cid/ciaf387 Baldanzi G, et al. Antibiotic use and gut microbiome composition links from individual-level prescription data of 14,979 individuals. Nat Med 2026. doi: https://doi.org/10.1038/s41591-026-04284-y.Quentin Vallé, et al. Evaluating the antibacterial activity of ceftazidime/avibactam and aztreonam combinations against multidrug-resistant Stenotrophomonas maltophilia complex isolates in a hollow fibre infection model.  Clin Microbiol Infect 2026. doi: https://doi.org/10.1016/j.cmi.2026.02.010 Rana AI, et al. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. NEJM 2026. doi: https://doi.org/10.1056/NEJMoa2508228 Donovan J, et al. Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial. Nat Med 2026. doi: https://doi.org/10.1038/s41591-025-04138-z Further readingThwaite GE, et al. Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults. NEJM 2004. doi: https://doi.org/10.1056/NEJMoa040573 Behrmann LV. “The specimen is never wrong”: the pathologist behind Wolbachia. CMI Communications, 2026. doi: https://doi.org/10.1016/j.cmicom.2026.105185                

Fiscalía propone defensores públicos en el caso de Maduro. Irán rechaza el alto al fuego de Estados Unidos y propone su propio plan. Vacuna contra Lyme logra eficacia en pruebas avanzadas. Un joven de 15 años asesina a dos maestras en la escuela de México. Aumenta el crédito por hijos, pero excluye a padres con ITIN. Conoce los posibles riesgos de la marihuana en los jóvenes. Ponte al día con lo mejor de ‘La Edición Digital del Noticiero Univision' con Carolina Sarassa y Borja Voces.

Avanza rehabilitación de bajopuentes en TlalpanDespliegan 50 mil agentes por Semana SantaDeslave afecta zona cercana a Machu PicchuMás información en nuestro Podcast#grc

Providing primary health care in a war zone presents some extraordinary challenges. This presentation delves into the complex world of healthcare delivery amid conflict and chaos.

Superan 31 millones de vacunas contra sarampión aplicadas en México Alerta por gusano barrenador en Tamaulipas Día MeteorológicoMundial llama a la acción climáticaMás información en nuestro podcast#grc

TWiP reviews the effectiveness of long-lasting spatial repellent emanators against malaria in humanitarian crisis settings in northern Nigeria, and Dengue suppression by male Wolbachia-infected mosquitoes. Hosts: Vincent Racaniello, Daniel Griffin, and Christina Naula Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Links for this episode Join the MicrobeTV Discord server Spatial emanators for malaria control (Lancet Inf Dis) Dengue suppression with Wolbachia-infected mosquitoes (NEJM) Singapore Environmental Health Institute (TWiV 630) TWiP study – information and survey Become a patron of TWiP  Send your questions and comments to twip@microbe.tv

#MillicentEidson #MayaMaguire #MicrobialMysteries #MayaVerse #MedicalMystery #Zoonoses #PublicHealthFiction #Epidemiology #ClimateChangeFiction #Anthracis #Borrelia #Corona #Dengue #StorycomicPresents #IndieAuthor   In this episode of Storycomic Presents, I'm joined by veterinary epidemiologist–turned–mystery author Dr. Millicent Eidson, creator of the alphabetical Maya Maguire Microbial Mystery series. Drawing on decades of work at the Centers for Disease Control and Prevention and state health departments in New Mexico and New York, she's built the “MayaVerse,” where a veterinary medical detective chases real-life zoonotic diseases—microbes that jump from animals to people. We dig into Maya's world, starting with Anthracis: A Microbial Mystery, and moving through Borrelia, Corona, and Dengue, now collected in the new MayaVerse A–D Book Collection. The series blends medical thriller, mystery, and climate fiction as Maya and her colleagues confront anthrax outbreaks, tick-borne relapsing fever, COVID-19, and dengue in places like Arizona, New Mexico, and Hawai‘i. We also talk about why Dr. Eidson believes fiction is a powerful way to help readers understand pandemics, climate-driven disease, and public health work; how her adopted Chinese American heroine Maya reflects both her own family and the people she's worked with; and how her teaching at the University at Albany and University of Vermont shaped these stories. Learn more and find all the books at DrMayaMaguire.com and via the https://morganquaid.com/   Storycomic Logo designed by Gregory Giordano See more of Greg's work at: https://www.instagram.com/gregory_c_giordano_art/   Want to start your own podcast?  Click on the link to get started: https://www.podbean.com/storycomic   Follow us: Are you curious to see the video version of this interview?  It's on our website too! www.storycomic.com www.patreon.com/storycomic www.facebook.com/storycomic1 https://www.instagram.com/storycomic/ For information on being a guest or curious to learn more about Storycomic? Contact us at info@storycomic.com   Thank you to our Founders Club Patrons, Michael Winn, Higgins802, Von Allan, Stephanie Nina Pitsirilos, Marek Bennett, Donna Carr Roberts, Andrew Gronosky, Simki Kuznick, and Matt & Therese. Check out their fantastic work at: https://marekbennett.com/ https://www.hexapus-ink.com/ https://www.stephanieninapitsirilos.com/ https://www.vonallan.com/ https://higgins802.com/ https://shewstone.com/ https://www.simkikuznick.com/ Also to Michael Winn who is a member of our Founders Club!

Tanvi is an evolutionary biologist who studies how pathogens and microbial communities evolve in response to human ecological, environmental, and cultural changes. Employing a One Health framework, her work integrates genomic/metagenomic datasets derived from animals, contemporary human populations living diverse lifestyles, and ancient individuals recovered using innovative paleogenomics techniques. She have a Bachelor's degree in Microbiology, with a minor in Industrial Microbiology, and a Master's degree in Virology from the University of Pune, India. Her research career began in 2011 with her Masters' research project, where she conducted a case-control association study of genetic polymorphisms in human immune response genes and the outcomes of Dengue virus infection in Indian populations. From 2012 to 2017, she worked on her Ph.D. in Evolutionary Biology under the supervision of Dr. Anne Stone and Dr. Michael Rosenberg at Arizona State University, Tempe, U.S. Her dissertation research involved using cutting-edge degraded DNA and next-generation sequencing methods to elucidate the evolutionary histories of the pathogens causing two major human diseases - leprosy and tuberculosis. From 2017 to 2024, she worked as a Research Assistant Professor with Dr. Cecil M. Lewis Jr., in the Laboratories of Molecular Anthropology and Microbiome Research (LMAMR) at the University of Oklahoma, Norman, U.S. In this role, she co-led numerous projects investigating the evolution of the human microbiome in response to migration, lifeways, and behavior, which included a National Science Foundation-funded project on the oral microbiome. In 2025, she started a new position as a Bioinformatics Scientist working with Dr. Charlotte Avanzi at Colorado State University, where she is studying the transmission dynamics of leprosy in human and animal hosts. ------------------------------ Find the paper discussed in this episode: Honap, T. P., Monroe, C. R., Johnson, S. J., Jacobson, D. K., Abin, C. A., Austin, R. M., Sandberg, P., Levine, M., Sankaranarayanan, K., & Lewis, C. M. Jr. (2023). Oral metagenomes from Native American Ancestors reveal distinct microbial lineages in the pre-contact era. American Journal of Biological Anthropology, 182(4), 542–556. https://doi.org/10.1002/ajpa.24735 ------------------------------ Contact Dr. Honap: tanvi.honap@uzh.ch https://www.tanvihonap.com/ ------------------------------ Contact the Sausage of Science Podcast and Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Chris Lynn, Co-Host Website: cdlynn.people.ua.edu/, E-mail: cdlynn@ua.edu, Twitter:@Chris_Ly Cara Ocobock, Co-Host, Website: sites.nd.edu/cara-ocobock/, Email:cocobock@nd.edu, Twitter:@CaraOcobock Anahi Ruderman, SoS Co-Producer, HBA Junior Fellow / E-mail: ruderman@cenpat-conicet.gob.ar

Senado impulsa declarar el 9M “Día Nacional Sin Nosotras”EU descarta devolver aranceles recaudados por TrumpMás información en nuestro Podcast

Ceniza del Popocatépetl no afectaría a la CDMX Museo Militar de Aviación celebra aniversario con rodada y exhibicionesGobierno transitorio de Perú descarta indulto a Pedro CastilloMás información en nuestro podcast

In this powerful podcast, virologist Dr Basu Dev Pandey breaks down the science behind the Nipah Virus, its symptoms, transmission, and whether there is any cure for Nipah Virus today. We explore the growing concern around a potential Nipah Virus pandemic, why bats are considered a major carrier, and how virus mutation increases global health risks. Dr Pandey explains the difference between Encephalitis Virus, Japanese Encephalitis Virus, and Dengue Virus, clarifying how these infections impact the brain and immune system. The discussion also covers the 100 Days Vaccine Mission and how rapid vaccine development, including mRNA vaccine technology, could prevent the next pandemic. Learn how mRNA vaccines work, how viruses mutate, and how PCR machines are used to detect infections early. We also examine the current Nepal virus situation, the availability of Dengue treatment, and the present encephalitis outbreak risks. Most importantly, we ask the big question: Are we ready for the next pandemic? This in-depth virologist interview provides expert insights into pandemic preparedness, vaccine development, and global health threats. If you want to understand Nipah Virus symptoms, emerging virus risks, and the science behind future outbreak prevention, this episode is a must-watch.

Have you longed to integrate your Christian faith into your patient care—on the mission field abroad, in your work in the US, and during your training? Are you not sure how to do this in a caring, ethical, sensitive, and relevant manner? This “working” session will explore the ethical basis for spiritual care and provide you with professional, timely, and proven practical methods to care for the whole person in the clinical setting. https://www.dropbox.com/scl/fi/qpah9kh1lttg6cm1jjop9/Bob-Mason-Ethics-of-Spiritual-Care-revised.pptx?rlkey=0emve2ja8282nv8xc4uinq1hg&st=9033htwx&dl=0

In this news report, I look at what the Brazil Ministry of Health is doing to vaccinate 1.2 million healthcare workers against dengue fever, using their homegrown vaccine.

Frederico Amorim convida Ayrton Silveira e Flávio Barbieri para falar sobre diagnóstico de arboviroses em 4 partes:- Quando suspeitar?- Diferenças entre as arboviroses (dengue, chikungunya e zika)- Quais exames pedir?- Abordagem geralReferências:1. Pan American Health Organization. Recommendations for Laboratory Detection and Diagnosis of Arbovirus Infections in the Region of the Americas. Washington, D.C.: PAHO; 2023. Available from: https://doi.org/10.37774/9789275125878.2. WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.3. Rosenberger, Kerstin D et al. “Early diagnostic indicators of dengue versus other febrile illnesses in Asia and Latin America (IDAMS study): a multicentre, prospective, observational study.” The Lancet. Global health vol. 11,3 (2023): e361-e372. doi:10.1016/S2214-109X(22)00514-94. https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/a/aedes-aegypti/monitoramento-das-arboviroses5. Dengue : diagnóstico e manejo clínico : adulto e criança [recurso eletrônico] / Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de Doenças Transmissíveis. 6. ed. – Brasília : Ministério da Saúde, 2024.6. Shahsavand Davoudi, Amirhossein et al. “Ultrasound evaluation of gallbladder wall thickness for predicting severe dengue: a systematic review and meta-analysis.” The ultrasound journal vol. 17,1 12. 3 Feb. 2025, doi:10.1186/s13089-025-00417-57. Shabil, Muhammed et al. “Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis.” Expert review of anti-infective therapy vol. 23,1 (2025): 105-118. doi:10.1080/14787210.2024.24487218. Tsheten, Tsheten et al. “Clinical predictors of severe dengue: a systematic review and meta-analysis.” Infectious diseases of poverty vol. 10,1 123. 9 Oct. 2021, doi:10.1186/s40249-021-00908-29. Boletim Epidemiológico – Monitoramento das arboviroses e balanço de encerramento do COE Dengue e outras Arboviroses 2024,Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Volume 55, nº 11, 4 jul. 202410. Daumas, Regina P et al. “Clinical and laboratory features that discriminate dengue from other febrile illnesses: a diagnostic accuracy study in Rio de Janeiro, Brazil.” BMC infectious diseases vol. 13 77. 8 Feb. 2013, doi:10.1186/1471-2334-13-7711. Kamble N, Kumar VS, Rangaswamy DR, Kavatagi K. When it itches, dengue switches off: a retrospective case series. Bull Natl Res Cent. 2024;48:68. doi:10.1186/s42269-024-01225-y

John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information in Vizient's Center for Pharmacy Practice Excellence and Vizient's vaccine subject matter expert, joins host Stacy Lauderdale to discuss key updates to the CDC's childhood Immunization schedule and what they mean for practice.   Guest speaker:     John Schoen, PharmD, BCPS   Senior Clinical Manager of Evidence-Based Medicine and Drug Information    Vizient Center for Pharmacy Practice Excellence     Host:   Stacy Lauderdale, PharmD, BCPS   Associate Vice President  Vizient Center for Pharmacy Practice Excellence   Verified Rx Host    00:00 — Introduction Announcer welcomes listeners to Verified Rx, produced by the Vizient Center for Pharmacy Practice Excellence. 00:14 — Episode Overview Host Stacy Lauderdale introduces the topic: updates to the CDC's U.S. Childhood Immunization Schedule, revised January 20, 2026. Goal of the episode: explain what changed, what didn't, and what it means in practice for providers, pharmacists, and families. Guest: John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information at Vizient and vaccine subject matter expert. 01:16 — What Changed in the CDC Immunization Schedule CDC reorganized the schedule into three recommendation categories. Vaccines were reclassified, not removed. Number of diseases covered under “routine” recommendations decreased from 17 to 11 due to recategorization. 01:50 — Stated Rationale Behind the Changes Rationale provided in executive summary of scientific assessment. The supporting scientific assessment is available online and referenced for transparency (link in resources below). 03:19 — Were Any Vaccines Removed? No vaccines were removed from the CDC schedule. Some vaccines were shifted into different recommendation categories. 03:40 — Category 1: Routine Childhood Vaccinations Vaccines still routinely recommended for all children include: MMR (measles, mumps, rubella) Polio Tdap / DTaP Hib (Haemophilus influenzae type B) Pneumococcal HPV Varicella (chickenpox) 04:27 — Category 2: Vaccines for High-Risk Populations Vaccines recommended for children who meet specific high-risk criteria: RSV monoclonal antibodies (mAb) Hepatitis A Hepatitis B Quadrivalent meningococcal Meningococcal group B Dengue 05:19 — What Changed vs. Stayed the Same Hepatitis A, Hepatitis B, and quadrivalent meningococcal moved from routine to high-risk RSV mAb recommendations are effectively unchanged, as high-risk infants are defined as those born to mothers who did not receive the maternal RSV vaccine. Dengue remains risk-based. Meningococcal group B remains a mix of risk-based and shared clinical decision-making. 06:31 — Category 3: Shared Clinical Decision Making (SCDM) Defined by ACIP as an individualized decision made jointly by provider and parent/guardian. Allows vaccination when risk-based criteria are not met but benefit is still considered. 06:52 — Vaccines Under SCDM Vaccines now include: Influenza COVID-19 Rotavirus Hepatitis A Hepatitis B Quadrivalent meningococcal Meningococcal group B 08:05 — What's New in SCDM Influenza and rotavirus moved from routine to SCDM. Hepatitis A, hepatitis B, and quadrivalent meningococcal also shifted. COVID-19 moved to SCDM in September 2025 for individuals ≥6 months. 08:28 — Insurance Coverage Implications No expected changes in coverage. Vaccines recommended by CDC as of December 31, 2025 remain: Covered without cost-sharing under Affordable Care Act (ACA) plans. Covered by Medicaid, Children's Health Insurance Program (CHIP), and Vaccines for Children (VFC) program. 09:14 — Impact on Pharmacy Vaccine Access Pharmacists are considered healthcare providers under CDC SCDM definitions. Authority to administer vaccines primarily determined by state laws. Standing orders, protocols, and collaborative practice agreements may need to be updated, as applicable, to address language related to ‘routine' immunizations for children. 10:27 — Recommendations for Providers & Organizations For providers: Become familiar with schedule changes. Be prepared for patient and parent education. Recognize differences between CDC and other professional guidelines. For organizations: Review EHR documentation and order sets. Consult local state regulations to ensure compliance with vaccine administration practices. Review standing orders/protocols and collaborative practice agreements to determine if revisions are needed. Monitor vaccine utilization and adjust inventory accordingly. 11:24 — Resources & Closing Additional CDC and Vizient resources will be linked in the show notes. Announcer closes with subscription and feedback reminder. Links | Resources:    Additional resources HHS press release on changes to childhood immunizations schedule Assessment of US childhood and adolescent immunization schedule HHS fact sheet: CDC childhood immunization schedule Revised CDC child and adolescent immunization schedule ACIP shared clinical decision-making recommendations   Vizient resource Minute Market Insight   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed  

TWiV explains how the dengue virus protein NS1 alters Aedes aegypti midgut permeability and favors virus dissemination, and achieving a complete hepatitis B virus cure in chronic hepatitis B virus-infected humanized mice by using a capsid assembly modulator. Hosts: Vincent Racaniello, Alan Dove, and Angela Mingarelli Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV ASV 2026 Positions in Rosenfeld Lab (email) Dengue virus NS1 alters mosquito midgut permeability (mBio) HBV cure with a capsid assembly modulator (Cell Host Microbe) Letters read on TWiV 1289 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Angela – How hibernating bears maintain muscle mass Alan – The flood of Chinese grad students in the 2000s was a boon to US students. Vincent – Feynman Lectures on Physics Listener Picks David – Stewart Cheifet, Host of TV's 'Computer Chronicles,' Dies at 87 Charles – Last Year, and the Year to Come Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.